Catalyst Pharmaceuticals Inc (CPRX) Insider Trading
- $5,728,674.40
- $58,129,414.05
- Sept. 8, 2025
- Patrick J Mcenany
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| April 27, 2015 | Director | 15,000 | $3.71 | Buy | $55,650.00 | |
| April 27, 2015 | CEO | 5,000 | $3.79 | Buy | $18,950.00 | |
| April 24, 2015 | Director | 5,000 | $3.80 | Buy | $19,000.00 | |
| March 27, 2015 | Director | 5,000 | $4.17 | Buy | $20,850.00 | |
| Jan. 20, 2015 | EVP | 21,000 | $2.96 | Buy | $62,160.00 | |
| Jan. 13, 2015 | Director | 10,000 | $3.00 | Buy | $30,000.00 | |
| Jan. 8, 2015 | CEO | 50,000 | $2.80 | Buy | $140,000.00 | |
| Oct. 3, 2014 | VP | 10,000 | $2.65 | Buy | $26,500.00 | |
| June 4, 2014 | COO | 100,000 | $2.17 | Buy | $217,000.00 | |
| May 21, 2014 | CEO | 25,000 | $1.89 | Buy | $47,250.00 | |
| May 19, 2014 | Director | 10,000 | $1.83 | Buy | $18,300.00 | |
| April 16, 2014 | Director | 5,000 | $2.02 | Buy | $10,100.00 | |
| Feb. 7, 2014 | CEO | 25,000 | $1.82 | Buy | $45,500.00 | |
| Feb. 5, 2014 | Director | 10,000 | $1.81 | Buy | $18,100.00 | |
| Oct. 23, 2013 | Director | 8,000 | $2.03 | Buy | $16,240.00 | |
| Oct. 21, 2013 | CEO | 50,000 | $1.59 | Buy | $79,500.00 | |
| Oct. 21, 2013 | Director | 10,000 | $1.84 | Buy | $18,400.00 | |
| Feb. 19, 2013 | CEO | 50,000 | $0.46 | Buy | $23,000.00 | |
| Dec. 17, 2012 | CEO | 100,000 | $0.45 | Buy | $45,000.00 | |
| Dec. 8, 2012 | Major Shareholder | 5,000,000 | $0.75 | Buy | $3,750,000.00 | |
| Nov. 15, 2012 | CEO | 100,000 | $0.42 | Buy | $42,000.00 | |
| Nov. 15, 2012 | Director | 24,000 | $0.41 | Buy | $9,840.00 |
Insiders are both buying and selling Catalyst Pharmaceuticals Inc stock.
The insider traders at Catalyst Pharmaceuticals Inc are: Patrick J Mcenany, Charles B O'keeffe, Alicia Grande, Gary Ingenito, Steve Miller, Donald A Denkhaus, David S Tierney, Brian Elsbernd, Philip H Coelho, Preethi Sundaram, David D Muth, Carmen Jeffrey Del, Charles O'keeffe, Patrick Mcenany, Molly Harper, Richard J Daly, Biomarin Pharmaceutical Inc, and M Douglas Winship
The most active insider trader at Catalyst Pharmaceuticals Inc is Patrick J Mcenany with 22 trades.
Steve Miller has sold the most Catalyst Pharmaceuticals Inc stock with a total value of $15,250,567.70.
Biomarin Pharmaceutical Inc has bought the most Catalyst Pharmaceuticals Inc stock with a total value of $7,500,000.00.
The most recent insider trade for Catalyst Pharmaceuticals Inc was on Sept. 8, 2025.
The single biggest insider buy for Catalyst Pharmaceuticals Inc was from Biomarin Pharmaceutical Inc with a total value of $3,750,000.00 on Dec. 8, 2012.
The single biggest insider sell for Catalyst Pharmaceuticals Inc was from Patrick J Mcenany with a total value of $5,467,000.00 on Nov. 18, 2022.